Status:
RECRUITING
Making ART Work Among Brazilian Youth
Lead Sponsor:
Brown University
Collaborating Sponsors:
University of California, Los Angeles
Oswaldo Cruz Foundation
Conditions:
Hiv
Adherence, Medication
Eligibility:
MALE
18-24 years
Phase:
NA
Brief Summary
This study seeks to develop and pilot test a theory-based, integrated technology and counseling intervention to improve ART adherence among sexual and gender minority (SGM) young people living with HI...
Detailed Description
Background. Sexual and gender minority (SGM) youth account for the largest number of incident HIV infections in Brazil. Although HIV can be managed with ongoing antiretroviral therapy (ART), exception...
Eligibility Criteria
Inclusion
- between 18 and 24 years of age
- assigned male sex at birth
- identify as a gay or bisexual man, or a transgender woman or another gender identity along the feminine spectrum
- self-report living with HIV, and verified by medical chart review,
- self-report currently taking or prescribed ART for \> 3 months
- self-report missing 2 or more doses of ART medications in any given week in the past month OR not virally suppressed (i.e., \>40 copies/mL in past 3 months; via national outpatient data \[SISCEL\] or plasma viral load testing)
- owns a cell phone or willing to use one as part of the study
Exclusion
- unable to give informed consent due to cognitive limitation, severe mental/physical illness or intoxication
- unable to read and/or write to an extent that would limit their ability to comprehend the informed consent
- lived in the greater Rio de Janeiro area for \< 3 months or planning to move outside the area within the next year
Key Trial Info
Start Date :
October 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 30 2026
Estimated Enrollment :
72 Patients enrolled
Trial Details
Trial ID
NCT06056037
Start Date
October 1 2023
End Date
April 30 2026
Last Update
September 19 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Evandro Chagas National Institute of Infectious Diseases (INI) Oswaldo Cruz Foundation (FIOCRUZ)
Rio de Janeiro, Brazil